# Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic Sclerosis

> **NCT01347008** · PHASE3 · COMPLETED · sponsor: **Federal University of São Paulo** · enrollment: 41 (actual)

## Conditions studied

- Scleroderma, Systemic
- Scleroderma, Diffuse
- Scleroderma, Limited
- Raynaud Phenomenon

## Interventions

- **DRUG:** Sildenafil citrate
- **DRUG:** Placebo (Sugar pill)

## Key facts

- **NCT ID:** NCT01347008
- **Lead sponsor:** Federal University of São Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2016-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01347008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01347008, "Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic Sclerosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01347008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*